Skip to main content
. 2023 Jan 18;11(2):217. doi: 10.3390/vaccines11020217

Table 1.

Demographic, anthropometric, clinical and behavioral characteristics of the subjects included in the study.

Total Sample Women Men
Enrolled people 152 58.82% 41.18%
Mean age (± SD)
(min–max)
43.91 (±12.03)
(26–67)
44.55 (±11.64)
(26–67)
42.81 (±12.61)
(26–64)
Mean SARS-CoV2 antibody response (AU/mL)
(min–max)
214.51
(min 3.8; max ≥ 400)
209.23
(min 3.8; max ≥ 400)
229.02
(min 3.8; max ≥ 400)
Mean BMI (±SD)
(min–max)
25.76 (±5.3)
(18.82–44.92)
25.71 (±6.60)
(18.82–44.92)
26.02 (±2.71)
(22.86–32.91)
Comorbidities (%) 33.33% 34.61% 31.58%
Physical activity at work
 Moderate 42.22% 44.00% 36.84%
 Mild/slight 31.11% 32.00% 31.58%
 None 26.67% 24.00% 31.58%
Intensive physical activity 31.11% 11.5% 61%
Light physical activity 46.67% 42.31% 55.5%
Smoking habits
 smokers 22.22% 23.08% 22.22%
 former smokers 13.33% 7.69% 21.05%
Frequency of alcohol consumption
 non-drinkers 54.35% 69.23% 36.84%
 occasional drinkers 23.91% 19.23% 31.58%
 moderate drinkers 21.74% 7.69% 31.58%
Vitamin D (ng/mL)
(min–max)
23.10
(4.4–60.7)
23.62
(4.4–60.7)
21.47
(5.7–36.7)